证券之星消息,4月22日博时基金旗下万琼管理的博时恒生医疗保健交易型开放式指数基金(QDII)公布一季报,近1年净值增长率38.19%。与上一季度相比,该基金前十大重仓股新增再鼎医药;其中药明生物持仓占比10.82%,为该基金第一大重仓股;国药控股等退出前十大重仓股;详细数据如下:以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.